Envestnet Asset Management Inc. Buys 23,690 Shares of Danaher Corporation $DHR

Envestnet Asset Management Inc. increased its stake in shares of Danaher Corporation (NYSE:DHR) by 1.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,379,654 shares of the conglomerate’s stock after purchasing an additional 23,690 shares during the period. Envestnet Asset Management Inc. owned approximately 0.20% of Danaher worth $273,530,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. WFA of San Diego LLC bought a new position in Danaher during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new stake in Danaher in the second quarter worth $27,000. TruNorth Capital Management LLC bought a new position in shares of Danaher during the third quarter worth $28,000. Tripletail Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter valued at $31,000. Finally, Heartwood Wealth Advisors LLC acquired a new position in shares of Danaher in the 3rd quarter valued at $37,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the transaction, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts recently commented on DHR shares. TD Cowen reaffirmed a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. HSBC raised their price target on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. JPMorgan Chase & Co. boosted their price objective on Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, January 29th. Robert W. Baird set a $251.00 target price on Danaher in a research note on Thursday, January 29th. Finally, Evercore ISI restated an “outperform” rating and set a $254.00 target price on shares of Danaher in a report on Wednesday, January 28th. Twenty investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $252.32.

Danaher Stock Down 1.7%

Shares of Danaher stock opened at $215.70 on Friday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The business’s 50 day simple moving average is $229.81 and its 200 day simple moving average is $214.68. The firm has a market cap of $152.36 billion, a PE ratio of 42.80, a P/E/G ratio of 2.97 and a beta of 0.91.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same period last year, the company earned $2.14 earnings per share. The firm’s revenue was up 4.6% compared to the same quarter last year. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were issued a $0.32 dividend. The ex-dividend date was Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 25.40%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.